Catching pancreatic cancer early is among the most difficult challenges faced by medical providers, and that delay often ends ...

Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major ...

In 2026, an estimated 67,530 people will be diagnosed with pancreatic cancer, according to the American Cancer Society. But ...

A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and ...

A new four-marker blood test accurately detects pancreatic cancer, including early stages, raising hopes for earlier diagnosis and improved survival pending further studies. Scientists backed by the ( ...

Knowable Magazine reports on advancements in pancreatic cancer treatment, including new drugs, vaccines, and early diagnostic technologies promising improved survival rates.

A novel four-protein biomarker blood panel promotes early pancreatic cancer detection, identifying 91.9% of cancer cases and surpassing standard tests.

A new blood test could improve survival rates for pancreatic cancer – a disease which often tends to be diagnosed at later ...

National Institutes of Health (NIH)-supported investigators have developed a blood test to find pancreatic ductal ...

A Mayo Clinic study is providing new insights into how treatment sequence can affect survival in patients with early-stage ...